Forget P&G: Colgate-Palmolive Defensive Cash Flow Beats Earnings
Colgate-Palmolive (CL) beats earnings and shows stronger defensive cash flow than Procter & Gamble (PG), making it a compelling buy in volatile markets.
Key Numbers
A recent analysis from 24/7 Wall St. suggests that Colgate-Palmolive (NYSE:CL) may be a better pick than Procter & Gamble (NYSE:PG) for investors seeking defensive cash-flow stocks. While PG is the traditional go-to in retirement portfolios during market turbulence, internal metrics indicate CL is outperforming.
Cash Flow Superiority
Colgate-Palmolive reported stronger cash flow than Procter & Gamble in the most recent quarter, making it more attractive for investors seeking stability and returns. The company also beat earnings estimates, reinforcing its position as a defensive powerhouse.
Comparison with P&G
Although PG boasts a $350.4 billion market cap and is the default consumer defensive trade, its internal performance may be less appealing. In contrast, CL offers a better mix of growth and cash flow.
What This Means for Investors
For investors looking to hedge against market volatility, Colgate-Palmolive may be a better investment than Procter & Gamble at this time. However, investors should evaluate their own objectives and risk tolerance before making any decisions.
Frequently Asked Questions
Found this useful? Share it